Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Diseases | 2 | 2019 | 172 | 0.560 |
Why?
|
| Genetic Therapy | 2 | 2016 | 687 | 0.550 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2024 | 206 | 0.520 |
Why?
|
| Macular Degeneration | 1 | 2016 | 115 | 0.460 |
Why?
|
| Diabetic Retinopathy | 2 | 2024 | 155 | 0.360 |
Why?
|
| Retinal Neovascularization | 1 | 2006 | 14 | 0.250 |
Why?
|
| Corneal Neovascularization | 1 | 2006 | 12 | 0.250 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 97 | 0.220 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 357 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2023 | 137 | 0.200 |
Why?
|
| Glaucoma | 1 | 2021 | 87 | 0.180 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 470 | 0.170 |
Why?
|
| Cataract | 1 | 2021 | 224 | 0.160 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2019 | 52 | 0.150 |
Why?
|
| Genetic Vectors | 2 | 2016 | 940 | 0.150 |
Why?
|
| Endophthalmitis | 1 | 2018 | 77 | 0.140 |
Why?
|
| Eye Infections, Bacterial | 1 | 2018 | 92 | 0.140 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2018 | 119 | 0.140 |
Why?
|
| Cataract Extraction | 1 | 2018 | 216 | 0.120 |
Why?
|
| Bevacizumab | 1 | 2015 | 64 | 0.120 |
Why?
|
| Choroidal Neovascularization | 1 | 2015 | 28 | 0.120 |
Why?
|
| Milk, Human | 1 | 2015 | 300 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1101 | 0.090 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1990 | 35 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 1203 | 0.090 |
Why?
|
| Animals | 6 | 2024 | 34235 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 826 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1990 | 256 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2431 | 0.070 |
Why?
|
| Rats, Inbred BN | 1 | 2006 | 16 | 0.060 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2006 | 37 | 0.060 |
Why?
|
| Macaca fascicularis | 1 | 2006 | 87 | 0.060 |
Why?
|
| Choroid | 1 | 2006 | 39 | 0.060 |
Why?
|
| Electroretinography | 1 | 2006 | 114 | 0.060 |
Why?
|
| Iris | 1 | 2006 | 65 | 0.060 |
Why?
|
| Fluorescein Angiography | 1 | 2006 | 138 | 0.060 |
Why?
|
| Rabbits | 1 | 2006 | 718 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 388 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 1290 | 0.050 |
Why?
|
| Retinal Vessels | 1 | 2023 | 75 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 1243 | 0.050 |
Why?
|
| HIV-1 | 1 | 2006 | 464 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2006 | 888 | 0.050 |
Why?
|
| Gene Expression | 1 | 2006 | 1560 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2021 | 144 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 553 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 847 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2021 | 491 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 512 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 573 | 0.040 |
Why?
|
| Retina | 1 | 2023 | 450 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 526 | 0.040 |
Why?
|
| Humans | 7 | 2024 | 125221 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 3727 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2024 | 2312 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 17633 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 510 | 0.030 |
Why?
|
| Blood-Retinal Barrier | 1 | 2015 | 3 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 4404 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 4395 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2015 | 146 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2015 | 221 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 412 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 1103 | 0.030 |
Why?
|
| Male | 4 | 2019 | 61539 | 0.020 |
Why?
|
| Thioguanine | 1 | 1990 | 21 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 1990 | 34 | 0.020 |
Why?
|
| Gentamicins | 1 | 1990 | 95 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1990 | 80 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1990 | 257 | 0.020 |
Why?
|
| Introns | 1 | 1990 | 300 | 0.020 |
Why?
|
| Plasmids | 1 | 1990 | 513 | 0.020 |
Why?
|
| Mutagenesis | 1 | 1990 | 345 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1990 | 226 | 0.020 |
Why?
|
| Glycols | 1 | 1988 | 6 | 0.020 |
Why?
|
| Self Mutilation | 1 | 1988 | 5 | 0.020 |
Why?
|
| Lesch-Nyhan Syndrome | 1 | 1988 | 11 | 0.020 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1988 | 35 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 1988 | 25 | 0.020 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1988 | 29 | 0.020 |
Why?
|
| Transfection | 1 | 1990 | 1069 | 0.020 |
Why?
|
| Exons | 1 | 1990 | 798 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1990 | 647 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3073 | 0.020 |
Why?
|
| Base Sequence | 1 | 1990 | 3102 | 0.020 |
Why?
|
| Movement Disorders | 1 | 1988 | 222 | 0.020 |
Why?
|
| Cell Line | 1 | 1990 | 2757 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1990 | 3891 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1990 | 2821 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 19363 | 0.010 |
Why?
|
| Phenotype | 1 | 1990 | 4262 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 19884 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 29644 | 0.010 |
Why?
|
| Female | 1 | 2015 | 66815 | 0.000 |
Why?
|
| Fluphenazine | 1 | 1988 | 5 | 0.000 |
Why?
|
| Carbidopa | 1 | 1988 | 18 | 0.000 |
Why?
|
| Catecholamines | 1 | 1988 | 59 | 0.000 |
Why?
|
| Tetrabenazine | 1 | 1988 | 39 | 0.000 |
Why?
|
| Levodopa | 1 | 1988 | 91 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1988 | 14026 | 0.000 |
Why?
|
| Child | 1 | 1988 | 24416 | 0.000 |
Why?
|